Finerenone improves albuminuria in adults with type 1 diabetes and chronic kidney disease
1. In this phase 3 trial involving patients with type 1 diabetes and chronic kidney disease, finerenone was associated with ...
1. In this phase 3 trial involving patients with type 1 diabetes and chronic kidney disease, finerenone was associated with ...
A phase 3 trial showed Kerendia reduced the risk of cardiovascular death by 16% compared to placebo. Hyperkalemia was greater ...
1. In this secondary analysis of the DECLARE-TIMI 58 trial, among 17,160 patients, dapagliflozin consistently reduced the risk of cardiovascular ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.